Assessment of Bioavailability of Oral Micronized Progesterone Using a Salivary Progesterone Enzymeimmunoassay

References

• Kincl F. A., Ciaccio L. A., Benagiano G. Increasing oral bioavailability of progesterone by formulation. J. Steroid Biochem. 1978; 9: 83–4
   Google Scholar
• Wentz A. C. Editorial. Obstet. Gynecol. Surv. 1981; 36: 32
   Google Scholar
• Hargrove J. T., Maxson W. S., Wentz A. C. Absorption of oral progesterone is influenced by vehicle and particle size. Am. J. Obstet. Gynecol. 1989; 161: 948–51
   PubMed Web of Science ®Google Scholar
• Maxson W. S., Hargrove J. T. Bioavailability of oral micronised progesterone. Fertil. Steril. 1985; 44: 622–6
   PubMed Web of Science ®Google Scholar
• Chakmajian Z. H., Zachariah N. Y. Bioavailability of progesterone with different modes ofadministration. J. Reprod. Med. 1987; 32: 443–8
   Google Scholar
• Tallon D. F., Gosling J. P., Buckley P. M., Dooley M. M., Cleere W. F., O'Dwyer E. M., Fottrell P. F. Direct solid phase enzymoimmunoassay of progesterone in saliva. Clin. Chem. 1984; 30: 1507–11
   PubMed Web of Science ®Google Scholar
• Folan J., Finn M. M., Gosling J. P., Fottrell P. F. Solid-phase enzymoimmunoassay of estrone in saliva. Clin. Chem. 1989; 35: 569–72
   Google Scholar
• Finn M. M., Gosling J. P., Tallon D. F., Madden A. T. S., Meehan F. P., Fottrell P. F. Normal salivary progesterone levels throughout the ovarian cycle as determined by a direct enzymoimmunoassay. Fertil. Steril. 1988; 50: 882–7
   PubMed Web of Science ®Google Scholar
• Finn M. M., Gosling J. P., Tallon D. F., Joyce L. A., Meehan F. P., Fottrell F. P. Follicular growth and corpus luteum function in women with unexplained infertility, monitored by ultrasonography and measurement of daily salivary progesterone. Gynecol. Endocrinol. 1989; 3: 297–308
   PubMed Web of Science ®Google Scholar
• Bolaji I. I., Tallon D. F., Meehan F. P., O'Dwyer E., Fottrell P. F. The return of post-partum fertility monitored by Bioavailability of micronized progesterone by salivary analysis enzymeimmunoassay for salivary progesterone. Gynecol. Endocrinol. 1992; 6: 37–48
   PubMed Web of Science ®Google Scholar
• Bolaji I. I., Tallon D. F., Fottrell P. F. Development and application of enzymoimmuno-assay for salivary sex steroids. J. Irish Coll. Phys. Surgeons 1992; 21: 117–25
   Google Scholar
• Armstrong N. A., James K. C., Pugh W. K. L. Drug migration into soft gelatin capsule shells and its effects on in vitro availability. J. Pharm. Pharmacol 1984; 36: 361–4
   PubMed Web of Science ®Google Scholar
• Mashchak C. A., Lobo R. A., Dozono-Takano R., et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am. J. Obstet. Gynecol. 1982; 144: 511–18
   PubMed Web of Science ®Google Scholar
• Walsh B. W., Schiff I., Rosner B., Greenberg L., Ravnicar V., Sacks F. M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 1991; 325: 1196–204
   PubMed Web of Science ®Google Scholar
• Morville R., Dray F., Reynier J., Barrat J. The bioavailability of natural progesterone given by mouth. Measurement of steroid concentrations in plasma, endometrium and breast tissue. J. Gynecol. Obstet. Biol. Rep. (Paris) 1982; 11: 355–63
   PubMed Web of Science ®Google Scholar
• Padwick M., Endacott J., Whitehead M. Pharmacokinetics of oral micronised progesterone. Maturitas 1984; 6: 161
   Google Scholar
• Little B., Billiar R. B., Jassani M., Kline I. T., Lin T.J., Schnatz P. Dynamic studies of progesterone secretion. Presented at the Proceedings of the 10th International Congress of Endocrinology. 1972. Excerpta Medica, Amsterdam, 864
   Google Scholar
• Whitehead M. I., Townsend P. T., Gill D. K., Collins W. P., Campbell S. Absorption and metabolism of oral progesterone. Br. Med. J. 1980; 280: 825–7
   PubMedGoogle Scholar
• Nillius S. J., Johansson E. D. B. Plasma levels of progesterone after vaginal, rectal or Bolaji et al. intramuscular administration of progesterone. Am. J. Obstet. Gynecol 1971; 110: 470–7
   PubMed Web of Science ®Google Scholar
• Villanueva B., Casper R. F., Yen S. S. C. Intravaginal administration of progesterone: enhanced absorption after estrogen treatment. Fertil. Stent 1984; 35: 433–7
   Google Scholar
• Ferre F., Uzan M., Jassens Y., Tanguy G., Jolivet A., Breuiller M., Sureau C., Cedard L. Oral administration of micronised natural progesterone in later human pregnancy, effects on progesterone and estrogen concentrations in the plasma, placenta, and myometrium. Am. J. Obstet. Gynecol 1984; 148: 26–34
   PubMed Web of Science ®Google Scholar
• Lane G., Siddle N. C., Ryder T. A., Pryse-Davies J., King R.J. B., Whitehead M. Dose-dependent effects of oral progesterone in the oestrogenised postmenopausal endometrium. Br. Med. J. 1983; 287: 1241–4
   PubMed Web of Science ®Google Scholar
• Bolaji I. I., Grimes H., Mortimer G., Tallon D., Fottrell P. F., O'Dwyer E. M. A prospective study of low-dose progesterone in oestrogenised post-menopausal women: effects on plasma lipids, lipoproteins and liver function parameters. 1992, Presented at the 26th British Congress of Obstetrics and Gynaecology. Manchester, July, abstr. 287
   Google Scholar
• Bolaji I. I., Mortimer G., Grimes H., O'Dwyer E. M. Endometrial response in oestrogenized postmenopausal women after treatment with oral progesterone: a prospective analysis. 1992, Presented at the 26th British Congress of Obstetrics and Gynaecology Manchester, July, abstr. 71
   Google Scholar
• Magos A. L., Brincat M., Studd J. W. W., Wardle P., Schlesinger P., O'Dowd T. Amenorrhoea and endometrial atrophy with continuous oral oestrogen and progestogen therapy in postmenopausal women. Obstet. Gynecol 1985; 65: 496–9
   PubMed Web of Science ®Google Scholar